Ignite Creation Date:
2024-05-06 @ 3:24 PM
Last Modification Date:
2024-10-26 @ 1:49 PM
Study NCT ID:
NCT04624854
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-20
First Post:
2020-10-27
Brief Title:
Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease DAPT-MVD
Sponsor:
Harbin Medical University
Organization:
Harbin Medical University
Study Overview
Official Title:
Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease DAPT-MVD A Prospective Multicenter Randomized Controlled Trial
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is a prospective multicenter parallel open-label randomized controlled superiority trial It is planned to recruit 8250 patients with multi-vessel diseaseMVD and the patients will be followed-up for at least 12 months after being implanted with a drug-eluting stent DES at one of 100 different centers All patients will be randomly divided into the treatment group and control group on a 11 basis based on a complete randomization
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None